SAN DIEGO -- Results from a small single-center study showed that treatment with a gene therapy involving the use of ...
Among these sensors, we further focused on the spatiotemporal dynamics of Rab10 and Rab4 activity during sLTP. We found that postsynaptic stimulation leads to the persistent inactivation of Rab10 and ...
The Company's first-class scientific team continues to make good progress with CBR and, once sufficient resources are provided, the Company anticipates moving new CBR-based product candidates into ...
ESO-T01 is the first in vivo BCMA CAR-T candidate to reach the clinical stageEarly clinical data are expected in second half of ...
Recently, gene correction has also shown promise. In principle, gene correction (eg, through lentiviral transduction of the patient’s own cells) should be possible in most loss of function genetic ...
As an alternative to the systemic delivery of immune checkpoint inhibitors, here the authors develop an in vivo gene-edit strategy using a conductive hydrogel-based electroporation system to ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback